336 related articles for article (PubMed ID: 37199341)
1. Role of PFKFB3-driven glycolysis in sepsis.
Xiao M; Liu D; Xu Y; Mao W; Li W
Ann Med; 2023 Dec; 55(1):1278-1289. PubMed ID: 37199341
[TBL] [Abstract][Full Text] [Related]
2. Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3.
Wang Z; Kong L; Tan S; Zhang Y; Song X; Wang T; Lin Q; Wu Z; Xiang P; Li C; Gao L; Liang X; Ma C
J Immunol; 2020 Apr; 204(8):2232-2241. PubMed ID: 32179636
[TBL] [Abstract][Full Text] [Related]
3. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.
Wang L; Cao Y; Gorshkov B; Zhou Y; Yang Q; Xu J; Ma Q; Zhang X; Wang J; Mao X; Zeng X; Su Y; Verin AD; Hong M; Liu Z; Huo Y
Pharmacol Res; 2019 Aug; 146():104292. PubMed ID: 31167111
[TBL] [Abstract][Full Text] [Related]
4. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
5. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
Jones BC; Pohlmann PR; Clarke R; Sengupta S
Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
[TBL] [Abstract][Full Text] [Related]
6. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis.
Hu X; Xu Q; Wan H; Hu Y; Xing S; Yang H; Gao Y; He Z
Lab Invest; 2020 Jun; 100(6):801-811. PubMed ID: 32051533
[TBL] [Abstract][Full Text] [Related]
7. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
[TBL] [Abstract][Full Text] [Related]
8. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis.
Mager CE; Mormol JM; Shelton ED; Murphy PR; Bowman BA; Barley TJ; Wang X; Linn SC; Liu K; Nelin LD; Hafner M; Liu Y
J Biol Chem; 2023 Apr; 299(4):103043. PubMed ID: 36803959
[TBL] [Abstract][Full Text] [Related]
10. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
11. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
Chesney J
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
13. Nuances of PFKFB3 Signaling in Breast Cancer.
Galindo CM; Oliveira Ganzella FA; Klassen G; Souza Ramos EA; Acco A
Clin Breast Cancer; 2022 Jun; 22(4):e604-e614. PubMed ID: 35135735
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation.
Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T
Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
16. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.
Cao Y; Zhang X; Wang L; Yang Q; Ma Q; Xu J; Wang J; Kovacs L; Ayon RJ; Liu Z; Zhang M; Zhou Y; Zeng X; Xu Y; Wang Y; Fulton DJ; Weintraub NL; Lucas R; Dong Z; Yuan JX; Sullivan JC; Meadows L; Barman SA; Wu C; Quan J; Hong M; Su Y; Huo Y
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13394-13403. PubMed ID: 31213542
[TBL] [Abstract][Full Text] [Related]
17. PFKFB3 promotes sepsis-induced acute lung injury by enhancing NET formation by CXCR4
Liu D; Xiao M; Zhou J; Wang P; Peng J; Mao W; Hu Y; Liu Y; Yin J; Ke L; Li W
Int Immunopharmacol; 2023 Oct; 123():110737. PubMed ID: 37543012
[TBL] [Abstract][Full Text] [Related]
18. Mice with a specific deficiency of Pfkfb3 in myeloid cells are protected from hypoxia-induced pulmonary hypertension.
Wang L; Zhang X; Cao Y; Ma Q; Mao X; Xu J; Yang Q; Zhou Y; Lucas R; Fulton DJ; Su Y; Barman SA; Hong M; Liu Z; Huo Y
Br J Pharmacol; 2021 Mar; 178(5):1055-1072. PubMed ID: 33300142
[TBL] [Abstract][Full Text] [Related]
19. The potential utility of PFKFB3 as a therapeutic target.
Bartrons R; Rodríguez-García A; Simon-Molas H; Castaño E; Manzano A; Navarro-Sabaté À
Expert Opin Ther Targets; 2018 Aug; 22(8):659-674. PubMed ID: 29985086
[TBL] [Abstract][Full Text] [Related]
20. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.
Yalcin A; Solakoglu TH; Ozcan SC; Guzel S; Peker S; Celikler S; Balaban BD; Sevinc E; Gurpinar Y; Chesney JA
Biochem Biophys Res Commun; 2017 Mar; 484(3):687-693. PubMed ID: 28161638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
